Alignment Healthcare, Inc.

Overview

Compare with Clover Health, Trupanion or Bright Health, or pick any stock.

• TickerALHC on Nasdaq¹
• IndustryHospital & Medical Service Plans¹
• HeadquartersOrange, California¹
• Incorporated inDE²
• Business address1100 W. Town And Country Road, Suite 1600, Orange, Ca 92868²
• Filer categoryLarge accelerated filer²

See how the biggest companies compare on our leaderboards

Alignment Healthcare was founded in 2013 with one mission: improve healthcare, one senior at a time. We pursue this mission by focusing on our core values:⁴ From its latest annual report

Corporate structure

Alignment Healthcare, Inc. sits at the top of its group. 12 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Alignment Healthcare, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Investments

Intangibles and goodwill

Properties, in its own words

Our corporate headquarters are located in Orange, California at 1100 W. Town and Country Rd, Suite 1600, where we lease approximately 47,321 square feet of office space under a lease that terminates in May 2030. We also have offices located in New York, New York; Las Vegas, Nevada; El Paso, Texas; Sahuarita, and Tucson, Arizona; and Venice, Florida. We also have small clinics located in Milpitas, Modesto and Downey, California; and Raleigh, North Carolina. We believe that our properties are generally suitable to meet

our needs for the foreseeable future. In addition, to the extent we require additional space in the future, we believe that it would be readily available on commercially reasonable terms.

Item 2 of the 10-K filed Feb 27, 2026.⁴

Leadership

Who has led Alignment Healthcare, Inc., and when. Pick a name to see everywhere that person has worked.

• Chief executive officerJohn E. Kao Mar 26, 2021 to now¹²
• ChairJoseph S. Konowiecki Nov 9, 2022 to Jul 16, 2024¹³
• PresidentMark D. Kent May 20, 2026 to now¹⁴
• PresidentDawn Christine Maroney Mar 26, 2021 to May 20, 2026¹⁵
• Chief financial officerJames M. Head May 2, 2025 to now¹⁶
• Chief financial officerRobert Thomas Freeman Mar 26, 2021 to May 2, 2025¹⁷
• Chief operating officerSebastian Burzacchi Dec 7, 2023 to now¹⁸

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

• Alignment Health Advantage Plan, Inc. California³
• Alignment Health Advisors, LLC Delaware³
• Alignment Health Insurance Company of Arizona, Inc. Arizona³
• Alignment Health Plan (f/k/a Honored Citizens Choice Health Plan, Inc.) California³
• Alignment Health Plan of Arizona, Inc. Arizona³
• Alignment Health Plan of Nevada, Inc. Nevada³
• Alignment Health Plan of North Carolina, Inc. North Carolina³
• Alignment Healthcare Holdco 1, LLC Delaware³
• Alignment Healthcare Holdco 2, LLC Delaware³
• Alignment Healthcare North Carolina, LLC North Carolina³
• Alignment Healthcare USA, LLC Delaware³

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Timeline

1. Oct 8, 20268-K Regulation FD disclosure⁴⁵
2. Jul 30, 20268-K Results of operations⁴⁶
3. Jun 9, 20268-K Shareholder vote⁴⁷
4. May 12, 20268-K Bylaws or fiscal year changed; Regulation FD disclosure⁴⁸
5. Apr 30, 20268-K Results of operations⁴⁹
6. Mar 4, 20268-K Entered a material agreement⁵⁰
7. Feb 26, 20268-K Results of operations⁵¹
8. Jan 12, 20268-K Regulation FD disclosure⁵²
9. Oct 30, 20258-K Results of operations⁵³
10. Sep 9, 20258-K Regulation FD disclosure⁵⁴
11. Jul 30, 20258-K Results of operations⁵⁵
12. Jun 11, 20258-K Shareholder vote⁵⁶
13. Mar 26, 2021New chief executive John E. Kao becomes CEO¹²

Calendar

Coming up

1. Oct 29, 2026 · After the closeReports results for the quarter ending Sep/2026 A year earlier it reported $0.02 a share, on Oct 30, 2025.⁵⁷

When it reported results

1. Jul 30, 2026Reported quarterly or annual results⁴⁶
2. Apr 30, 2026Reported quarterly or annual results⁴⁹
3. Feb 26, 2026Reported quarterly or annual results⁵¹
4. Oct 30, 2025Reported quarterly or annual results⁵³
5. Jul 30, 2025Reported quarterly or annual results⁵⁵
6. May 1, 2025Reported quarterly or annual results⁵⁸
7. Feb 27, 2025Reported quarterly or annual results⁵⁹
8. Oct 29, 2024Reported quarterly or annual results⁶⁰

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

741 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 52 major events, 413 insider forms, 39 large holders, 217 other. The latest 20:

1. Oct 8, 20268-K EDGAR
2. Oct 7, 20264 EDGAR
3. Oct 5, 2026SCHEDULE 13G/A EDGAR
4. Oct 5, 2026144 EDGAR
5. Sep 18, 20264 EDGAR
6. Sep 16, 20264 EDGAR
7. Sep 16, 2026144 EDGAR
8. Sep 11, 20264 EDGAR
9. Sep 11, 20264 EDGAR
10. Sep 10, 2026144 EDGAR
11. Sep 9, 2026144 EDGAR
12. Sep 9, 2026144 EDGAR
13. Aug 18, 20264 EDGAR
14. Aug 14, 2026144 EDGAR
15. Aug 13, 2026SCHEDULE 13G EDGAR
16. Aug 10, 20264 EDGAR
17. Jul 31, 2026SCHEDULE 13G EDGAR
18. Jul 30, 202610-Q EDGAR
19. Jul 30, 20268-K EDGAR
20. Jul 27, 2026SCHEDULE 13G/A EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

337 open-market trades by officers, directors and large owners since October 2021: 3 buys and 334 sales. Grants, option exercises and gifts are left out.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

• BlackRockSCHEDULE 13G/A, 4 filings Oct 17, 2025 to Oct 5, 2026⁶¹
• InvescoSCHEDULE 13G, 1 filing Aug 13, 2026⁶²
• VANGUARD PORTFOLIO MANAGEMENT LLCSCHEDULE 13G, 1 filing Jul 31, 2026⁶³
• GENERAL ATLANTIC, L.P.SCHEDULE 13G/A, 6 filings Feb 11, 2022 to May 15, 2026⁶⁴
• Wellington Management CompanySCHEDULE 13G/A, 3 filings Nov 12, 2025 to May 15, 2026⁶⁵
• VANGUARD GROUP INCSCHEDULE 13G/A, 5 filings Nov 4, 2024 to Mar 26, 2026⁶⁶
• FMR LLCSCHEDULE 13G, 7 filings Feb 9, 2022 to Feb 5, 2026⁶⁷
• CITADEL ADVISORS LLCSCHEDULE 13G/A, 2 filings Jul 10, 2025 to Nov 14, 2025⁶⁸
• Qatar Investment AuthoritySCHEDULE 13G, 1 filing Sep 24, 2025⁶⁹
• T. Rowe Price Investment Management, Inc.SCHEDULE 13G, 3 filings Feb 14, 2024 to Aug 14, 2025⁷⁰
• Warburg Pincus Private Equity XII, L.P.SCHEDULE 13G/A, 4 filings Feb 14, 2022 to Feb 14, 2025⁷¹
• James E. FlynnSCHEDULE 13G/A, 2 filings May 17, 2024 to Feb 13, 2025⁷²

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How Alignment Healthcare, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARAlignment Healthcare, Inc.¹
• CIK0001832466
• Employer ID (EIN)46-5596242⁴
• Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company⁴
• Incorporated inDelaware⁴
• Fiscal year endsDecember 31¹
• Industry code (SIC)6324 Hospital & Medical Service Plans¹
• SEC reviewing officeOffice of Finance, Division of Corporation Finance¹
• Business address1100 W. Town And Country Road, Suite 1600, Orange, CA 92868¹
• Phone844-310-2247¹
• Shares outstanding207,435,149 as of Jul 27, 2026¹¹
• Public float$2.1B as of Jun 30, 2025⁴
• AuditorDeloitte & Touche LLP, Costa Mesa, California PCAOB ID 34; it also attests to the company’s internal control over financial reporting⁴
• On EDGAR sinceDec 4, 2020¹
• Filings812 in all: 4 (412), 144 (189), 8-K (53), 3 (34), SCHEDULE 13G/A (18), 10-Q (17), SCHEDULE 13G (8), 4/A (7)¹
  All 32 form types

  CORRESP (7), SC 13G/A (7), DEFA14A (6), SC 13G (6), 10-K (5), DEF 14A (5), ARS (4), UPLOAD (4), 3/A (3), 424B7 (3), 424B4 (2), 8-K/A (2), DRS (2), DRS/A (2), DRSLTR (2), EFFECT (2), S-1 (2), S-1/A (2), S-3ASR (2), S-8 (2), 144/A (1), 8-A12B (1), CERT (1), PRE 14A (1)

• Latest filingsAnnual report (10-K) Feb 27, 2026
  Quarterly report (10-Q) Jul 30, 2026
  Proxy statement (DEF 14A) Apr 24, 2026
  Latest 8-K (8-K) Oct 8, 2026

Securities registered for trading

From the cover page of the 10-K filed Feb 27, 2026 (Section 12(b) of the Exchange Act).⁴

Risk factors and legal proceedings

The risks Alignment Healthcare, Inc. names in Item 1A of its 10-K filed Feb 27, 2026: 66 risks under these headings, as written.⁴

• Risks Related to Our Business
• We have a history of net losses, we anticipate increasing expenses in the future, and we may not be able to achieve or maintain profitability.
• Our growth strategy may not prove viable and we may not realize expected results.
• If we are unable to attract new members, our revenue growth will be adversely affected.
• If we do not design and price our products properly and competitively, if we are unable to develop new products and implement clinical initiatives to provide a better healthcare experience for our members, lower costs, and appropriately document the risk profile of our members, or if our estimates of benefits expense are inadequate, our profitability may be materially adversely affected.
• We may not be successful in maintaining or improving our Star ratings in future years, which may have a direct and substantial adverse impact on our revenue.
• If we fail to develop and maintain satisfactory relationships with care providers to service our members, our business may be adversely affected.
• If we fail to manage our growth effectively, we may be unable to execute our business plan, maintain high levels of service and member satisfaction or adequately address competitive challenges.
• The healthcare industry is highly competitive. There are many other healthcare plans and healthcare service providers, many of which have a longer operating history and substantially more resources, and there are few barriers to entry in the healthcare industry. This competition may have a material adverse effect on our business operations and financial position.
• We have entered into certain key contracts with large independent physician associations, hospitals and other provider networks to serve our membership base. The loss or renegotiation of any of these contracts could negatively impact our results.
• Cybersecurity breaches, loss of data and other disruptions could compromise sensitive information related to our business or our members, or prevent us from accessing critical information and expose us to liability, which could adversely affect our business and our reputation.
• Our use of machine learning and artificial intelligence, including within our AVA platform, may introduce operational, regulatory and legal risks that could adversely affect our business, financial condition and results of operations.

Legal proceedings

We are from time to time subject to, and are presently involved in, litigation and other legal proceedings. We believe that there are no pending lawsuits or claims that, individually or in the aggregate, may have a material effect on our business, financial condition or operating results. The results of any future claims or proceedings cannot be predicted with certainty, and regardless of the outcome, litigation can have an adverse impact on us because of defense and litigation costs, diversion of management resources, and other factors. For a discussion of our material legal actions, including those not in the ordinary course of business, see "Legal Proceedings" in Note 14 to the audited Consolidated Financial Statements included in Item 8. Financial Statements and Supplementary Data.

The opening of Item 3, Legal Proceedings.⁴